Glenmark Life Sciences Limited (GLS.BO)
INR 1085.8
(0.0%)
INR 1085.8
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 8.97 Billion INR | 5.93% |
| 2022 | 5.97 Billion INR | 3.51% |
| 2021 | 5.77 Billion INR | 4.11% |
| 2020 | 5.54 Billion INR | 32.57% |
| 2019 | 4.18 Billion INR | 106.24% |
| 2018 | 2.02 Billion INR | 1559800.0% |
| 2017 | -130 Thousand INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 1.19 Billion INR | -17.8% |
| 2024 Q1 | 1.45 Billion INR | 11.58% |
| 2023 Q1 | 1.8 Billion INR | -7.37% |
| 2023 FY | 6.32 Billion INR | 5.93% |
| 2023 Q3 | 1.59 Billion INR | 3.52% |
| 2023 Q2 | 1.53 Billion INR | -14.73% |
| 2023 Q4 | 1.3 Billion INR | -18.41% |
| 2022 Q1 | 1.36 Billion INR | 3.19% |
| 2022 FY | 5.97 Billion INR | 3.51% |
| 2022 Q4 | 1.94 Billion INR | 44.71% |
| 2022 Q3 | 1.34 Billion INR | 0.74% |
| 2022 Q2 | 1.33 Billion INR | -2.33% |
| 2021 Q1 | 1.51 Billion INR | -6.35% |
| 2021 Q2 | 1.57 Billion INR | 4.05% |
| 2021 Q3 | 1.36 Billion INR | -13.54% |
| 2021 Q4 | 1.32 Billion INR | -2.69% |
| 2021 FY | 5.77 Billion INR | 4.11% |
| 2020 FY | 5.54 Billion INR | 32.57% |
| 2020 Q4 | 1.61 Billion INR | 10.19% |
| 2020 Q3 | 1.46 Billion INR | 23.83% |
| 2020 Q2 | 1.18 Billion INR | -8.46% |
| 2020 Q1 | 1.29 Billion INR | 0.0% |
| 2019 FY | 4.18 Billion INR | 106.24% |
| 2018 FY | 2.02 Billion INR | 1559800.0% |
| 2017 FY | -130 Thousand INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | -55.94% |
| Aurobindo Pharma Limited | 42.2 Billion INR | 78.724% |
| Granules India Limited | 6.81 Billion INR | -31.723% |
| Indoco Remedies Limited | 1.29 Billion INR | -594.689% |
| Achyut Healthcare Limited | 4.43 Million INR | -202225.146% |
| Ajanta Pharma Limited | 19.67 Billion INR | 54.368% |
| Alkem Laboratories Limited | 19.46 Billion INR | 53.863% |
| Alpa Laboratories Limited | 184.49 Million INR | -4766.849% |
| Brooks Laboratories Limited | 14.44 Million INR | -62082.756% |
| AstraZeneca Pharma India Limited | 1.71 Billion INR | -422.806% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -629.422% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 86.742% |
| Eris Lifesciences Limited | 5.18 Billion INR | -73.286% |
| FDC Limited | 2.98 Billion INR | -200.688% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | -38.091% |
| Gufic Biosciences Limited | 1.32 Billion INR | -575.173% |
| Ind-Swift Laboratories Limited | 4.42 Billion INR | -103.124% |
| Ipca Laboratories Limited | 7.98 Billion INR | -12.513% |
| Jagsonpal Pharmaceuticals Limited | 508.13 Million INR | -1667.105% |
| Krebs Biochemicals & Industries Limited | -151.95 Million INR | 6009.033% |
| Lasa Supergenerics Limited | -458 Million INR | 2060.5% |
| Laurus Labs Limited | 3.94 Billion INR | -127.402% |
| Lupin Limited | 28.04 Billion INR | 67.982% |
| Mankind Pharma Limited | 21.51 Billion INR | 58.271% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Medico Remedies Limited | 100.3 Million INR | -8852.333% |
| Megasoft Limited | -121.1 Million INR | 7514.445% |
| NATCO Pharma Limited | 25.96 Billion INR | 65.414% |
| Piramal Pharma Limited | 4.55 Billion INR | -97.046% |
| RPG Life Sciences Limited | 2.29 Billion INR | -291.711% |
| Sigachi Industries Limited | 1.47 Billion INR | -509.215% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 91.391% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -94.876% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -3502.469% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Wanbury Limited | 569.71 Million INR | -1476.082% |
| Windlas Biotech Limited | 1.29 Billion INR | -591.297% |
| ZIM Laboratories Limited | 253.82 Million INR | -3437.496% |
| Zydus Lifesciences Limited | 43.1 Billion INR | 79.17% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 318.204% |
| Divi's Laboratories Limited | 33.08 Billion INR | 72.856% |
| Hester Biosciences Limited | 364.81 Million INR | -2361.333% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -222.297% |
| Amrutanjan Health Care Limited | 457.54 Million INR | -1862.476% |
| Bal Pharma Limited | 233.9 Million INR | -3738.754% |
| Strides Pharma Science Limited | 5.22 Billion INR | -71.824% |
| Venus Remedies Limited | 534.65 Million INR | -1579.449% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -187.048% |
| Nectar Lifesciences Limited | 923.8 Million INR | -871.978% |
| Shilpa Medicare Limited | 1.36 Billion INR | -557.204% |
| Aarti Drugs Limited | 7.14 Billion INR | -25.606% |
| IOL Chemicals and Pharmaceuticals Limited | 1.59 Billion INR | -462.324% |
| Suven Life Sciences Limited | -1.22 Billion INR | 832.504% |
| Ind-Swift Limited | 1.22 Billion INR | -632.419% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.28 Billion INR | 37.133% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 333.05% |
| Themis Medicare Limited | 392.58 Million INR | -2187.173% |
| Hikal Limited | 32.11 Million INR | -27863.843% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 64.558% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Novartis India Limited | 626.5 Million INR | -1333.231% |
| Wockhardt Limited | -670 Million INR | 1440.178% |
| Jubilant Pharmova Limited | 5.18 Billion INR | -73.043% |
| Biofil Chemicals and Pharmaceuticals Limited | 9.06 Million INR | -98912.979% |
| Neuland Laboratories Limited | 5.31 Billion INR | -68.842% |
| Morepen Laboratories Limited | 4.17 Billion INR | -115.131% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -4215.881% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -32601.544% |